FDA Clears AI Breast Cancer Tool
The FDA cleared Clarity Health's AI breast cancer screening tool as healthcare organizations accelerate AI deployments…
AI in healthcare — diagnostics, drug discovery, clinical workflows, and what it means for patients and providers.
The FDA cleared Clarity Health's AI breast cancer screening tool as healthcare organizations accelerate AI deployments…
Healthcare AI adoption accelerated in 2026 through major pharmaceutical partnerships and new infrastructure developments, with particular…
Healthcare organizations have deployed over 1,300 AI implementations across drug discovery, diagnostic imaging, and hospital operations.…
Healthcare organizations are rapidly adopting AI across clinical diagnosis, drug discovery, and patient care, with over…
The FDA has approved 47 new AI medical devices in Q1 2026, while hospitals deploy AI…
Healthcare organizations are rapidly deploying AI systems across clinical workflows, from diagnostic tools to drug discovery…
The FDA has approved over 520 AI medical devices as healthcare organizations rapidly deploy artificial intelligence…
The AI healthcare market has reached $15 billion in 2026, driven by accelerated FDA approvals and…
Researchers unveiled DeepER-Med, an AI framework that outperforms existing medical research platforms through transparent evidence synthesis.…
The FDA has approved over 300 AI healthcare systems in 2026, accelerating deployment across hospitals and…